BioMaric

Foundation date

13/08/2001

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

BioMaric is a Belgian biotechnology company specialised in the development of diagnostic assays for infectious diseases (such as HIV, HCV and HTLV) used for blood bank screening and laboratory diagnostics.

Upcoming events

Latest news

  • argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis

    Thursday September 21st 2023

  • Galapagos appoints Simon Sturge to its Board of Directors

    Tuesday September 19th 2023

  • 13th Investment for HERAN Partners: Broken String Biosciences (UK)

    Tuesday September 19th 2023